Mi1250 Synchrony 2 Flexsoft
Payments companies reported to CMS as associated with Mi1250 Synchrony 2 Flexsoft. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Mi1250 Synchrony 2 Flexsoft, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Mi1250 Synchrony 2 Flexsoft
These are the largest totals companies reported as associated with Mi1250 Synchrony 2 Flexsoft. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Hinrich Staecker | Kansas City, KS | $245,737.77 | |
| Kevin Brown | Chapel Hill, NC | Otology & Neurotology | $126,843.32 |
| Thomas Balkany | Miami, FL | Otology & Neurotology | $87,500.00 |
| Jacob Hunter | Philadelphia, PA | Otology & Neurotology | $46,693.49 |
| John Mcelveen | Raleigh, NC | Otology & Neurotology | $35,882.31 |
| Seilesh Babu | Farmington Hills, MI | Otology & Neurotology | $27,745.50 |
| Todd Hillman | Pittsburgh, PA | Otology & Neurotology | $27,216.51 |
| Bruce Gantz | Iowa City, IA | Otolaryngology | $22,806.42 |
| Oliver Adunka | Columbus, OH | Otolaryngology | $22,776.74 |
| Nancy Young | Chicago, IL | Pediatric Otolaryngology | $20,763.60 |
Prescribed Mi1250 Synchrony 2 Flexsoft?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.